Medication info

Lansone Capsule (Lansoprazole Granules)

Prescription medicationHard capsuleOralExpired
Ingredient · strength
Lansoprazole Granules›353mg / 1 capsule
Manufacturer / importer
Medix Pharmaceutical Co., Ltd.
Appearance
A hard capsule with white or almost white spherical or oval granules filled inside.
Packaging
30 capsules/bottle, 100 capsules/bottle
Approval status
Expired

MFDS item code 201904455 · Approved 2019.06.28

This product's status changed to Expired on 2024.06.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of peptic ulcer disease (including eradication and prevention of recurrence), gastroesophageal reflux disease, and gastric acid hypersecretion
Who takes it
Adults · Children
Adult dose
This drug should be administered before meals. For patients who have difficulty swallowing the medication, open the capsule, mix the contents with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. To ensure the full dose is taken, rinse the glass with twice or more the amount of juice and drink immediately. After opening the capsule, do not chew or crush the contents before taking them. Short-term treatment of active duodenal ulcers: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcers: Administer lansoprazole 30 mg with clarithromycin 250–500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if needed. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcers: Administer lansoprazole 30 mg with amoxicillin 1,000 mg three times daily (every 8 hours) for 14 days. Maintenance therapy after treatment of duodenal ulcers: Administer lansoprazole 15 mg orally once daily. The comparative clinical trial period did not exceed 12 months. Treatment of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. Reduction of the risk of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 15 mg orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease: Administer lansoprazole 15 mg orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance therapy after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome: The dosage of lansoprazole for pathological hypersecretory conditions varies by patient. Treatment in adults is usually initiated at 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of 90 mg per administration have been given up to twice daily. If the daily dose exceeds 120 mg, it should be given in divided doses. Because clearance of this drug is reduced in older adults, dosage adjustment is necessary. Do not exceed a daily dose of 30 mg. Because metabolism and excretion of this drug may be delayed in patients with hepatic impairment, administer cautiously, including consideration of dosage adjustment.
Child dose
Children and adolescents 12–17 years of age, short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents 12–17 years of age, short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children 1–11 years of age, 30 kg or less: 15 mg once daily for 12 weeks Children 1–11 years of age, over 30 kg: 30 mg once daily for 12 weeks

Ingredients

Manufacturer
Medix Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of peptic ulcer disease (including eradication and prevention of recurrence), gastroesophageal reflux disease, and gastric acid hypersecretion

  • Active duodenal ulcer
  • active benign gastric ulcer
  • duodenal ulcer
  • NSAID-induced gastric ulcer
  • symptoms related to gastroesophageal reflux disease
  • erosive esophagitis
  • Zollinger-Ellison syndrome
  • pathological hypersecretion states.
View approved original text

This medication is used for the short-term treatment of active duodenal ulcers and benign gastric ulcers. It also helps in eradicating Helicobacter pylori to prevent the recurrence of duodenal ulcers. It prevents the recurrence of duodenal ulcers and erosive esophagitis as part of maintenance therapy after treatment. It is effective for the treatment of gastric ulcers caused by non-steroidal anti-inflammatory drugs and for reducing the risk of occurrence. It is used for the short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive esophagitis. Lastly, this medication is used to treat pathological hypersecretion states such as Zollinger-Ellison syndrome.

How to take

Adult dose

This drug should be administered before meals. For patients who have difficulty swallowing the medication, open the capsule, mix the contents with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. To ensure the full dose is taken, rinse the glass with twice or more the amount of juice and drink immediately. After opening the capsule, do not chew or crush the contents before taking them. Short-term treatment of active duodenal ulcers: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcers: Administer lansoprazole 30 mg with clarithromycin 250–500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if needed. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcers: Administer lansoprazole 30 mg with amoxicillin 1,000 mg three times daily (every 8 hours) for 14 days. Maintenance therapy after treatment of duodenal ulcers: Administer lansoprazole 15 mg orally once daily. The comparative clinical trial period did not exceed 12 months. Treatment of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. Reduction of the risk of nonsteroidal anti-inflammatory drug-induced gastric ulcers: Administer lansoprazole 15 mg orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease: Administer lansoprazole 15 mg orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance therapy after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome: The dosage of lansoprazole for pathological hypersecretory conditions varies by patient. Treatment in adults is usually initiated at 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of 90 mg per administration have been given up to twice daily. If the daily dose exceeds 120 mg, it should be given in divided doses. Because clearance of this drug is reduced in older adults, dosage adjustment is necessary. Do not exceed a daily dose of 30 mg. Because metabolism and excretion of this drug may be delayed in patients with hepatic impairment, administer cautiously, including consideration of dosage adjustment.

Child dose

Children and adolescents 12–17 years of age, short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents 12–17 years of age, short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children 1–11 years of age, 30 kg or less: 15 mg once daily for 12 weeks Children 1–11 years of age, over 30 kg: 30 mg once daily for 12 weeks

Precautions

This medication should not be used in patients with an allergy to certain ingredients or a history of hypersensitivity to benzimidazole derivatives. Caution is also required for patients who are allergic to penicillin or macrolide antibiotics when co-administering this drug. The use of this medication is contraindicated in pregnant women or patients currently taking certain antiviral medications. This medication should be used with caution in patients with impaired liver function, the elderly, nursing mothers, and children. Severe side effects such as anaphylaxis, blood disorders, liver dysfunction, and serious skin reactions may occur infrequently; thus, if any unusual symptoms appear, immediate consultation with a healthcare professional is necessary. Prolonged use may lead to side effects such as vitamin B12 deficiency, increased risk of fractures, and hypomagnesemia, necessitating regular check-ups. During treatment, dizziness, drowsiness, and visual disturbances may occur, so caution is advised when driving or operating machinery. This medication can interact with other drugs, so it is essential to inform your doctor or pharmacist if taking antibiotics, antiviral medications, anticoagulants, immunosuppressants, etc. It is safer to avoid this medication during pregnancy or breastfeeding; if it must be used, breastfeeding should be discontinued. In the case of overdose, visit a medical institution immediately and receive gastric lavage or treatment as required based on symptoms. Keep this medication out of the reach of children, do not transfer it to other containers, and avoid using automatic dispensers for tablet forms.

Side effects

Anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute interstitial nephritis, urticaria, generalized rash, facial edema, dyspnea, shock, pancytopenia, agranulocytosis, hemolytic anemia, granulocytopenia, thrombocytopenia, anemia, jaundice, elevated AST, elevated ALT, toxic liver dysfunction, toxic epidermal necrolysis, mucocutaneous syndrome, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, fever, cough, abnormal lung sounds, interstitial nephritis, acute renal failure, membranous colitis, hematochezia, abdominal pain, frequent diarrhea, headache, diarrhea, abdominal distension, allergic reaction, back pain, weakness, candidiasis, cancer, chills, chest pain, edema, fever, flu-like symptoms, halitosis, infection, fatigue, neck stiffness, pelvic pain, angina, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, vasodilation, syncope, asthma, bronchitis, increased cough, epistaxis, hemoptysis, hiccups, pneumonia, upper respiratory infection, laryngeal tumor, pulmonary fibrosis, pharyngitis, pleural disorder, respiratory disorder, rhinitis, sinusitis, wheezing, abnormal stools, enteritis, gastritis, gastrointestinal abnormalities, gastrointestinal diseases, gastrointestinal bleeding, loss of appetite, gastric stones, pyloric spasm, cholelithiasis, constipation, thirst, xerostomia, dyspepsia, dysphagia, belching, esophageal stricture, esophageal ulcer, esophagitis, stool discoloration, abdominal distension, gastric nodules, gastric fundic polyps, gastroenteritis, upper gastrointestinal bleeding, hematemesis, increased appetite, increased saliva, anal bleeding, stomatitis, tongue disorders, glossitis, gingival bleeding, delayed defecation, colitis, vomiting, nausea, candidiasis of the gastrointestinal tract, rectal disorders, rectal bleeding, diabetes mellitus, goiter, hypothyroidism, anemia, bleeding, lymphadenopathy, vitamin deficiency, gout, hyperglycemia, hypoglycemia, dehydration, weight gain, weight loss, peripheral edema, bone diseases, joint diseases, leg cramps, arthritis, arthralgia, musculoskeletal pain, myalgia, myasthenia, ptosis, synovitis, agitation, amnesia, anxiety, apathy, confusion, depression, dizziness, syncope, hallucinations, unilateral paralysis, exacerbation of hostility, decreased libido, increased libido, neurosis, sensory abnormalities, abnormal thoughts, convulsions, dementia, depersonalization, diplopia, hyperactivity, hypertonia, sensory loss syndrome, insomnia, sleep disorders, drowsiness, tremors, acne, hair loss, pruritus, rashes, contact dermatitis, dry skin, nail disorders, skin cancer, skin diseases, sweating, abnormal vision, amblyopia, blepharitis, cataracts, conjunctivitis, dry eyes, ear disorders, eye disorders, glaucoma, abnormal olfaction, photophobia, retinal degeneration, loss of taste, blurred vision, deafness, eye pain, otitis media, taste disturbance, tinnitus, visual field constriction, urinary disorders, kidney pain, penile disorders, testicular disorders, urethral pain, polyuria, frequent urination, urinary retention, menstrual irregularities, chest tenderness, chest expansion, gynecomastia, diabetes, hematuria, erectile dysfunction, nephrolithiasis, anaphylactic-like reaction, hepatotoxicity, vomiting, pancreatitis, abdominal pain, taste alterations, aplastic anemia, granulocytopenia, leukopenia, neutropenia, thrombocytopenic purpura, eosinophilia, hypomagnesemia, Clostridium difficile-associated diarrhea, fracture, myositis, erythema multiforme, acute generalized exanthematous pustulosis, speech impairment, urinary retention, elevated ALP, elevated LDH, elevated γ-GTP, weakness, hyponatremia, increased total cholesterol, decreased total cholesterol, tongue paralysis, lip paralysis, limb paralysis, constipation, taste disturbance, ribbon-like stools, abdominal bloating, nausea, stomatitis, glossitis, heartburn, gastroesophageal reflux, neutropenia, eosinophilia, leukocytosis, thrombocytopenia, rash, pruritus, drowsiness, insomnia, paralysis, depressive state, elevated triglycerides, increased uric acid, positive urine protein, positive urine glucose, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container as it may be sensitive to air and moisture. It is important to maintain storage temperatures between 1-30 degrees Celsius to keep the medication effective for a longer period.

Appearance and packaging

Appearance

A hard capsule with white or almost white spherical or oval granules filled inside.

Package unit

30 capsules/bottle, 100 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.